Biophysics×Bioinformatics

The Frontier Brief for this collision is still being written. The evidence below already reflects the current model run.

Pre-company space. No named players have staked this collision yet — an emerging pairing where the field, not a firm, is the story so far.

30 researchers publish on both sides of this collision without the fields themselves having met. Every name below is counted from papers in the corpus — not inferred.

• Michele VendruscoloInstitute of Science and Technology Austria
  6/2
• Christopher M. DobsonUK Dementia Research Institute
  9/1
• Hans CleversLustgarten Foundation
  1/7
• Radostin DanevThermo Fisher Scientific (Netherlands)
  4/1
• F. Ulrich HartlMax Planck Society
  2/2
• Denise WoottenThermo Fisher Scientific (Netherlands)
  3/1
• Patrick M. SextonMonash Institute of Medical Research
  3/1
• Wilhelm T. S. HuckRadboud University Nijmegen
  3/1
• Fabrizio ChitiUnited States Military Academy
  1/2
• Rachel M. JohnsonMonash Institute of Medical Research
  2/1

• Harvard UniversityUS
  105/63
• Howard Hughes Medical InstituteUS
  109/28
• University of CambridgeGB
  55/35
• ETH ZurichCH
  56/28
• University of California, San FranciscoUS
  54/26
• University College LondonGB
  37/35

• Evolving cryo-EM structural approaches for GPCR drug discovery2021 · 74 citations · DOI ↗
  1
• CircRNA: functions and properties of a novel potential biomarker for cancer2017 · 1,677 citations · DOI ↗
  2
• Chemistry of Lipid Nanoparticles for RNA Delivery2021 · 849 citations · DOI ↗
  2
• Semiconducting Polymer Nanobioconjugates for Targeted Photothermal Activation of Neurons2016 · 461 citations · DOI ↗
  2

Counted from the corpus. Institution counts use best-effort affiliation (every author on a paper is paired with every institution on it), so read them as presence, not headcount.